Q&A with Industry Veteran Jim Spavins
Summary: In nearly 40 years at Pfizer and in consulting, Spavins has helped many scientists make the jump from academic approaches to the needs of the boardroom. We sat down with Jim, a board member of the Catalent Applied Drug Delivery Institute, to discuss what founders must consider when launching a biotech startup, how to navigate complex regulatory and funding challenges, and the benefits of partnering with trusted contract development and manufacturing organizations (CDMOs) like Catalent.